- Promoting innovation and access to affordable medicinal products
- Specific rules for novel medicines such as orphan drugs and antimicrobials
- Medicines to become more environmentally sustainable
MEPs adopted their proposals to revamp EU pharmaceutical legislation, to foster innovation and enhance the security of supply, accessibility and affordability of medicines.
On
Tuesday, the Environment, Public Health and Food Safety Committee
adopted its position on the new directive (66 votes in favour, two
against and nine abstentions) and regulation (67 votes in favour, six
against and seven abstentions) covering medicinal products for human
use. (...)
Post
Nessun commento:
Posta un commento